Background: mRNA expression signatures are frequently used as surrogate measures of cellular function and pathway changes. Few studies have directly compared results obtained using gene expression and multiplex protein assays for corresponding gene products.
Introduction
With the development of microarray technology for gene expression (1) and multiplexing technologies for protein measurements (2) , scientists are able to study many molecular candidate markers including both mRNA and protein markers. Gene array technologies permit global evaluation of expression patterns in a way that is currently not yet possible at the protein level due to the proteome complexity. Because biological processes are typically driven by proteins, mRNA expression signature results are often thought of as a proxy for functional pathway changes, which involve changes in protein levels. This requires the assumption that global differences in mRNA levels reflect differences in protein levels. Few studies have attempted to directly compare mRNA expression and protein measures to determine how closely mRNA expression levels reflect levels of their corresponding proteins and those that have revealed weak to moderate correlations between these markers (3-6).
As part of our effort to understand immunologic responses following vaccination with the new virus-like particle (VLP) human papillomavirus (HPV) vaccine (7-9), we have measured gene expression profiles (using the Human Genome Focus Array from the Affymetrix GeneChip) and levels of cytokines/chemokines (using a bead-based multiplex cytokine assay developed by Linco Research, Inc.) in cultured peripheral blood mononuclear cells (PBMC) obtained from individuals vaccinated with an HPV-16 VLP vaccine. This provided the opportunity for us to directly compare results obtained from an expression array with those obtained by directly measuring protein levels of cytokines in supernatants from the same biological specimens. Here, we report the results from this direct comparison and the implications of our findings.
Materials and Methods

Study design
Details of our study design have been reported previously (9) . In brief, we studied 26 (19 vaccine recipients and 7 placebo recipients) women 18 to 25 y of age who participated in a phase II clinical trial of an HPV-16 L1 VLP vaccine without adjuvant (Novavax) conducted at the Johns Hopkins Center for Immunization Research (9) . Blood specimens used for our evaluation were collected from participants before the first vaccine dose was administered (pre-vax) and at month 2 (1 mo after the second dose was administered; post-vax). Cryopreserved PBMCs obtained from the blood specimens were used to perform the assays described below. The Johns Hopkins University Institutional Review Board approved the protocol for this study.
Laboratory methods
Microarray gene expression analysis and multiplex cytokine assay were done on PBMC cultures after 72 h of culturing as previously described (7) (8) (9) . In brief, cryopreserved PBMCs were thawed and cultured (10 × 10 6 cells total; cultured at 2.0 × 10 6 cells/mL in a volume of 5 mL) for 72 h at 37°C. Cells were cultured in single wells in vitro with HPV-16 L1 VLP (2.5 μg/mL), influenza A virus (Flu, H3N2, 1:100; American Type Culture Collection), Sf9/baculovirus insect cell lysate (BAC, 0.1 μg/mL; Novavax), or medium. Medium was used as a background measurement for untreated cells. Supernatants and cell pellets were obtained from the same well. Cell-free supernatants were aliquoted, frozen at −80°C, and then subsequently thawed for cytokine/chemokine testing in duplicate using the 22-plex cytokine assay developed by Linco Research, as previously described (8) . Remaining supernatant and cell pellets were used for the total RNA extractions, frozen at −80°C, and subsequently used for microarray gene expression testing using the Affymetrix Human Genome Focus Array as previously described (7).
Statistical analysis
Analysis of the expression array data was limited to the probes that mapped to genes coding for the cytokines/chemokines in our multiplex panel (listed in Table 1 ). IL-7 and IL-12 protein expression levels were below the detection limits for all specimens tested and these two cytokines were therefore not considered further for this analysis.
Expression values in the media-alone culture were considered as background measurements. Expression values in treated cultures (VLP, Flu, and BAC) were corrected for background by subtracting the results of the mediaalone culture. In a similar fashion, cytokine values were expressed as the levels observed after subtraction of background levels observed in the media-alone culture. The means of duplicate cytokine values were used for the analysis. The resultant values were used to address the question of whether individual assay results correlated with each other. In addition, because we were interested in determining whether changes in immune responses over time (i.e., post-vax responses relative to pre-vax responses) could be evaluated using mRNA-and protein-based arrays, differences in expression and protein levels post-vax minus pre-vax were also calculated and compared.
We used the Spearman correlation to determine the magnitude of the correlation between gene expression and its corresponding protein level. We present the results in table format that combines vaccine and placebo recipients, the various culture conditions used, and the two time points tested (unless otherwise noted). Notable findings from analyses that stratified on these factors are presented in the text.
Results
As shown in Table 1 and Fig. 1 , correlations between gene expression and secreted protein levels varied for the various markers evaluated. When we evaluated all results regardless of condition or time point, the strongest correlation was observed for IFN-γ (R = 0.90, P < 0.0001). Correlations that were 0.60 or higher were observed for an additional three markers: MIP1A (R = 0.78, P < 0.0001), IP10 (R = 0.62, P < 0.0001), and TNF-α (R = 0.60, P < 0.0001). Modest correlations on the order of 0.40 to 0.59 were observed for five markers: MCP1 (R = 0.56, P < 0.0001), IL-2 (R = 0.55, P < 0.0001), GM-CSF (R = 0.53, P < 0.0001), IL-5 (R = 0.41, P < 0.0001), and RANTES (R = 0.41, P < 0.0001). When changes over time (post-vax minus pre-vax) were evaluated, we typically observed weaker correlations (−0.39 to 0.69) than those observed when all results were evaluated (−0.01 to 0.90). The strongest correlation between gene expression and protein levels was again observed for IFN-γ (R = 0.69, P < 0.0001). The only other markers where correlations of 0.40 or greater were observed were MCP1 (R = 0.56, P < 0.0001) and IL-8 (R = 0.49, P < 0.0001).
When the individual culture conditions were examined separately (VLP, FLU, and BAC), the correlations observed ranked similarly to the ranking observed using all conditions combined (Spearman correlation of the ranking of the correlations varied from 0.66 for FLU, all time points, to 0.90 for VLP, post-vax minus pre-vax), with the exception of BAC (Spearman correlation of the ranking of the correlations was 0.34). It is interesting to note that correlations were weakest for BAC (as expected because BAC was used as a negative control in our assay) and strongest for VLP.
Discussion
In this study, we directly compared gene expression and secreted protein levels for a set of cytokines/chemokines using gene microarray and protein multiplexing technologies.
Our results suggest that although for some cytokines/ chemokines, expression levels closely mirror protein levels (IFN-γ, MIP1A, IP10 , and TNF-α) or moderately parallel protein levels (IL-2, GM-CSF, IL-5, RANTES, and MCP1), for other markers this is not the case (IL-1A, IL-1B, IL-4, IL-6, IL-8, IL-10, IL-13, IL-17A, IL-17B , G-CSF, and eotaxin).
The imperfect and variable correlation between mRNA and protein levels is in agreement with previous reports (4, 10-13) and can be explained by posttranscriptional and posttranslational regulation and by misclassification due to measurement errors (14) (15) (16) (17) . The different levels of inaccuracy, noise, and sensitivity and dynamic ranges of the methods used for transcript and protein analysis likely contribute to the lack of correlation observed for several of the markers examined (18) (19) (20) (21) (22) (23) . In addition, the measurement of levels of secreted cytokines instead of total intracellular levels may also have contributed in part to the differences between the two measures.
The presence of misclassification error is supported by the lower correlations observed when the post-vax minus Figure 1 . Correlations between gene expression levels measured by microarray and protein levels of cytokines determined by Luminex bead arrays. All data are shown as log 2 and refer to all conditions and time points tested. X axis, protein levels (in pg/mL); Y axis, gene expression levels.
pre-vax measures were examined, as it involves the difference between two measures, each with error, making the error larger and therefore biasing the results toward the null. In addition, the lower correlations observed in post-vax minus pre-vax measures might arise from differences in dynamic range between the two assays. Alternative methods to measure gene expression levels, such as reverse transcription-PCR methods, might have a greater dynamic range and therefore theoretically allow for a more precise quantitation of expression levels than the microarray method (24) . This, in turn, could increase the agreement between RNA expression and protein measures. Having said this, our previous attempts to confirm microarray findings using reverse transcription-PCR methods have suggested that the expression pattern of the genes selected for confirmation concurred with the microarray data for a small subset of markers evaluated (7) .
Regardless of the exact reason for the lack of correlation observed (i.e., whether technical and/or true biological differences), individuals who use expression array tools should be mindful of the fact that levels of changes in expression detected by the Affymetrix microarrays do not always reflect the levels of changes in secreted proteins detected using currently available protein arrays. Thus, it is possible that different profiles/signatures may result from these two technologies.
In summary, our comparison of expression and protein levels for a set of 20 cytokines/chemokines suggests that the expression results obtained from microarrays do not necessarily correlate with the secreted protein levels detected by a Luminex-based technology. Investigators who use currently available expression array tools should be careful not to assume that mRNA expression changes identified by expression studies would necessarily reflect similar changes in corresponding protein levels. Improvement of gene probe set definition, method accuracy for absolute concentrations of DNA and protein, and use of proteomic techniques might help improve our understanding of the relationship between mRNA expression and protein production.
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